Wong A - Search Results

1

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.

Dorff T, Horvath LG, Autio K, Bernard-Tessier A, Rettig MB, Machiels JP, Bilen MA, Lolkema MP, Adra N, Rottey S, Greil R, Matsubara N, Tan DSW, Wong A, Uemura H, Lemech C, Meran J, Yu Y, Minocha M, McComb M, Penny HL, Gupta V, Hu X, Jurida G, Kouros-Mehr H, Janát-Amsbury MM, Eggert T, Tran B. Dorff T, et al. Among authors: wong a. Clin Cancer Res. 2024 Apr 15;30(8):1488-1500. doi: 10.1158/1078-0432.CCR-23-2978. Clin Cancer Res. 2024. PMID: 38300720 Clinical Trial.

2

Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer.

Ang D, Chan J, Ong WS, Tan HS, Ng QS, Yuen J, Chen K, Tay KJ, Wong SW, Saad M, Nagata M, Horie S, Chansriwong P, Ng CF, Wong A, Chua MLK, Toh CK, Tan MH, Lim T, Bhagat AAS, Kanesvaran R. Ang D, et al. Among authors: wong a, wong sw. JCO Precis Oncol. 2024 Jun;8:e2300694. doi: 10.1200/PO.23.00694. JCO Precis Oncol. 2024. PMID: 38905583

3

Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statements.

Chiong E, Murphy DG, Buchan NC, Chua MLK, Hakim L, Hamid AR, Hong SK, Horvath LG, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Malek R, Ng ACF, Vinh NT, Pang ST, Poon DMC, Ong TA, Saad M, Schubach K, Shiroki R, Türkeri L, Williams S, Wong A, Ye D; ANZUP Cancer Trials Group; Davis ID. Chiong E, et al. Among authors: wong a. Asia Pac J Clin Oncol. 2022 Dec;18(6):686-695. doi: 10.1111/ajco.13722. Epub 2022 Feb 8. Asia Pac J Clin Oncol. 2022. PMID: 35134266 Free PMC article.

4

Outcomes and prognostic predictors of Lu-177 PSMA radioligand therapy in metastatic castration-resistant prostate cancer (Asian Population Study).

Chua WM, Lam WW, Tong AK, Sultana R, Kua SMY, Kanesvaran R, Wong ASC, Tay KJ, Cheng TJL, Ng DCE, Thang SP. Chua WM, et al. Asia Pac J Clin Oncol. 2024 Oct;20(5):572-581. doi: 10.1111/ajco.13944. Epub 2023 Mar 31. Asia Pac J Clin Oncol. 2024. PMID: 36999335

5

An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore.

Kanesvaran R, Chia PL, Chiong E, Chua MLK, Ngo NT, Ow S, Sim HG, Tan MH, Tay KH, Wong ASC, Wong SW, Tan PH. Kanesvaran R, et al. Ann Acad Med Singap. 2023 Mar 30;52(3):135-148. doi: 10.47102/annals-acadmedsg.2022372. Ann Acad Med Singap. 2023. PMID: 38904491 Free article. Review.

6

Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience.

Chan J, Yap SY, Fong YC, Lim HC, Toh CK, Ng QS, Rajasekaran T, Chua M, Lee LS, Wong A, Loh KY, Chow M, Wong SW, Kanesvaran R. Chan J, et al. Among authors: wong a, wong sw. Asia Pac J Clin Oncol. 2020 Feb;16(1):75-79. doi: 10.1111/ajco.13241. Epub 2019 Nov 11. Asia Pac J Clin Oncol. 2020. PMID: 31713349

7

Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.

Thang SP, Lam WWC, Tong AKT, Allen JC Jr, Ler ASL, Tay YS, Somanesan S, Kanesvaran R, Wong ASC, Ng DCE. Thang SP, et al. Nucl Med Commun. 2020 Jul;41(7):618-628. doi: 10.1097/MNM.0000000000001179. Nucl Med Commun. 2020. PMID: 32282629 Clinical Trial.

8

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer.

Sooi K, Walsh R, Kumarakulasinghe N, Wong A, Ngoi N. Sooi K, et al. Among authors: wong a. Cancer Drug Resist. 2023 Sep 25;6(3):656-673. doi: 10.20517/cdr.2023.48. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37842236 Free PMC article. Review.

9

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer.

Huang Y, Zhao JJ, Soon YY, Wong A, Aminkeng F, Ang Y, Asokumaran Y, Low JL, Lee M, Choo JRE, Chan G, Kee A, Tay SH, Goh BC, Soo RA. Huang Y, et al. Among authors: wong a. Thorac Cancer. 2022 Nov;13(22):3152-3161. doi: 10.1111/1759-7714.14667. Epub 2022 Sep 30. Thorac Cancer. 2022. PMID: 36177913 Free PMC article.

10

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Soares A, Bourlon MT, Wong A, Joshi A, Jardim D, Korbenfeld E, Karak FE, Orlandi F, Sze H, Ansari J, Zarba J, Mansour MA, Manneh R, Thirumulai R, Tsai YC, Morsi WA, Powles T. Soares A, et al. Among authors: wong a. Clin Genitourin Cancer. 2024 Apr;22(2):467-475. doi: 10.1016/j.clgc.2024.01.001. Epub 2024 Jan 3. Clin Genitourin Cancer. 2024. PMID: 38228413 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,616 results

Search Page

Filters